HCW Biologics (HCWB) Revenue & Revenue Breakdown
HCW Biologics Revenue Highlights
Latest Revenue (Y)
$2.84M
Latest Revenue (Q)
$618.85K
HCW Biologics Revenue by Period
HCW Biologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.84M | -57.72% |
| 2022-12-31 | $6.72M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2019-12-31 | - | - |
HCW Biologics generated $2.84M in revenue during NA 2023, up -57.72% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
HCW Biologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $618.85K | -45.07% |
| 2024-03-31 | $1.13M | -14.90% |
| 2023-12-31 | $1.32M | 55.20% |
| 2023-09-30 | $853.10K | 36.98% |
| 2023-06-30 | $622.81K | 1387.02% |
| 2023-03-31 | $41.88K | -96.88% |
| 2022-12-31 | $1.34M | -25.84% |
| 2022-09-30 | $1.81M | 298.46% |
| 2022-06-30 | $454.00K | -85.44% |
| 2022-03-31 | $3.12M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
HCW Biologics generated $618.85K in revenue during Q2 2024, up -45.07% compared to the previous quarter, and up 1477.58% compared to the same period a year ago.
HCW Biologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MOLN | Molecular Partners | $7.04M | $2.74M |
| HCWB | HCW Biologics | $2.84M | $618.85K |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| MNOV | MediciNova | $1.00M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| PHVS | Pharvaris | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| PRDS | Pardes Biosciences | - | - |
| PEPG | PepGen | - | - |
| CSBR | Champions Oncology | - | - |
HCWB Revenue FAQ
What is HCW Biologics’s yearly revenue?
HCW Biologics's yearly revenue for 2023 was $2.84M, representing a decrease of -57.72% compared to 2022. The company's yearly revenue for 2022 was $6.72M, representing an increase of 100.00% compared to 2021. HCWB's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.
What is HCW Biologics’s quarterly revenue?
HCW Biologics's quarterly revenue for Q2 2024 was $618.85K, a -45.07% decrease from the previous quarter (Q1 2024), and a -0.63% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.13M, a -14.90% decrease from the previous quarter (Q4 2023), and a 2590.14% increase year-over-year (Q1 2023). HCWB's quarterly revenue for Q4 2023 was $1.32M, a 55.20% increase from the previous quarter (Q3 2023), and a -1.31% decrease year-over-year (Q4 2022).
What is HCW Biologics’s revenue growth rate?
HCW Biologics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.